Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

zoetis belgium sa - selamectin, sarolaner - nėra vaistai, insekticidai ir repelentai. - katės - katėms, arba gresia, sumaišyti parazitinės invazijos pagal erkių ir blusų, utėlių, erkių, virškinimo trakto nematodų ar heartworm. veterinarinis vaistas yra išimtinai nurodomas, kai jis naudojamas nuo erkių ir tuo pačiu metu nurodomas vienas ar daugiau kitų paskirtų parazitų.

Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

viiv healthcare b.v. - dolutegravir natrio, lamivudine - Živ infekcijos - antivirusiniai vaistai sisteminiam naudojimui - dovato fluorouracilu ir folino žmogaus imunodeficito viruso tipas 1 (Živ-1) infekcijos suaugusieji ir paaugliai, vyresni nei 12 metų amžiaus, sveria ne mažiau kaip 40 kg, nėra žinoma ar įtariama, atsparumą integrase inhibitorių klasės, arba lamivudine.

Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

astrazeneca ab - metforminas hidrochloridas, saxagliptin, dapagliflozin - cukrinis diabetas, 2 tipas - narkotikai, vartojami diabetu - qtrilmet yra nurodyta suaugusiems nuo 18 metų ir vyresni, su 2 tipo cukrinis diabetas:gerinti glycaemic kontrolės, kai metforminas su arba be sulfonilkarbamido dariniai (Šu) ir arba saxagliptin ar dapagliflozin neužtikrina adekvačios glycaemic kontrolės. kai jau gydomi metforminas ir saxagliptin ir dapagliflozin.

Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

abbvie deutschland gmbh & co. kg - upadacitinib - artritas, reumatas - imunosupresantai - rheumatoid arthritisrinvoq is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying anti-rheumatic drugs (dmards). rinvoq may be used as monotherapy or in combination with methotrexate. psoriatic arthritisrinvoq is indicated for the treatment of active psoriatic arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more dmards. rinvoq may be used as monotherapy or in combination with methotrexate. axial spondyloarthritisnon-radiographic axial spondyloarthritis (nr-axspa)rinvoq is indicated for the treatment of active non-radiographic axial spondyloarthritis in adult patients with objective signs of inflammation as indicated by elevated c-reactive protein (crp) and/or magnetic resonance imaging (mri), who have responded inadequately to nonsteroidal anti-inflammatory drugs (nsaids). ankylosing spondylitis (as, radiographic axial spondyloarthritis)rinvoq is indicated for the treatment of active ankylosing spondylitis in adult patients who have responded inadequately to conventional therapy. atopic dermatitisrinvoq is indicated for the treatment of moderate to severe atopic dermatitis in adults and adolescents 12 years and older who are candidates for systemic therapy. ulcerative colitisrinvoq is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent.  crohn’s diseaserinvoq is indicated for the treatment of adult patients with moderately to severely active crohn’s disease who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent.

Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

seqirus netherlands b.v. - a/darwin/9/2021 (h3n2) - like strain (a/darwin/6/2021, ivr-227) / a/victoria/4897/2022 (h1n1) pdm09-like strain (a/victoria/4897/2022, ivr-238) / b/phuket/3073/2013-like strain (b/phuket/3073/2013, bvr-1b) / influenza virus b/austria/1359417/2021-like strain (b/austria/1359417/2021, bvr-26) - gripas, žmogus - vakcinos - profilaktikai gripo vyresnio amžiaus (65 metų amžiaus ir vyresni). fluad tetra turėtų būti naudojami laikantis oficialių rekomendacijų.

Lietuva - lietuvių - SMCA (Valstybinė vaistų kontrolės tarnyba)

beaphar b.v. (nyderlandai) - užlašinamasis tirpalas - 0,5 ml pipetėje yra: fipronilo - 50,0 mg; - blusomis (ctenophalides felis) užsikrėtusioms katėms gydyti ir užsikrėtimo profilaktikai. vaistas apsaugo nuo pakartotinio užsikrėtimo blusomis iki 5 savaičių. kraujasiurbėmis erkėmis (ixodes ricinus) užsikrėtusioms katėms gydyti. ant gyvūno kūno esančios erkės (ixodes ricinus) žūsta per 48 val. veterinarinis vaistas neapsaugo nuo pakartotino užsikrėtimo kraujasiurbėmis erkėmis.

Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vakcinos - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. naudoti šios vakcinos turėtų būti laikantis oficialių rekomendacijų.

Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - eprinomectin, esafoxolaner, praziquantel - eprinomectin, combinations, , avermectins, antiparasitic products, insecticides and repellents - katės - for cats with, or at risk from mixed infections by cestodes, nematodes and ectoparasites. veterinarinis vaistas yra tik nurodyta, kada visi trys grupes tuo pačiu metu.

Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

amarin pharmaceuticals ireland limited - icosapent ethyl - dislipidemijos - lipidą keičiančios medžiagos - indicated to reduce cardiovascular risk as an adjunct to statin therapy.

Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

pfizer europe ma eeig - nirmatrelvir, ritonavir - covid-19 virus infection - paxlovid is indicated for the treatment of coronavirus disease 2019 (covid-19) in adults who do not require supplemental oxygen and who are at increased risk for progressing to severe covid 19.